Ledger.Open graph →
SEC Form D · filed March 12, 2021

K2 Biolabs, LLC

Offering
$5.5M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON , TX, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Andrew Strong · HOUSTON, TXDirectorKevin Slawin · HOUSTON, TXDirectorClifford Stocks · Seattle, WADirectorKieron Jones · HOUSTON, TXExec · DirectorAndrew Desomma · Tesuque, NMDirectorKieron Jones · HOUSTON, TXExec · DirectorAndrew Strong · HOUSTON, TXDirectorAndrew Desomma · Tesuque, NMDirectorKevin Slawin · HOUSTON, TXDirectorClifford Stocks · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗